on 14 Mar 2024
Last Applicant/ Owned by
Recursion Pharmaceuticals, Inc.
41 South Rio Grande StreetSalt Lake City UT 84101
US
Serial Number
2315467 filed on 13th Dec 2023
Correspondent Address
33 Yonge Street, Suite 300Toronto
ONTARIO
CA
M5E1G4
HEXAGON OF DOTS DESIGN
Vienna Information
24 . 17 . 1
Punctuation marksSignes de ponctuation
24 . 17 . 2
DotsPoints
25 . 7 . 1
Surfaces or backgrounds covered with repeated geometrical figures or designsSurfaces ou fonds couverts de figures ou de motifs géométriques répétés
25 . 7 . 6
Surfaces or backgrounds covered with circles or ellipsesSurfaces ou fonds couverts de cercles ou d'ellipses
25 . 7 . 7
Surfaces or backgrounds covered with dotsSurfaces ou fonds couverts de points
26 . 1 . 1
CirclesCercles
26 . 1 . 6
Several circles or ellipses, juxtaposed, tangential or intersectingPlusieurs cercles ou ellipses, juxtaposés, tangents ou se coupant
26 . 1 . 24
Circles or ellipses with dark surfaces or parts of surfacesCercles ou ellipses avec surface ou partie de la surface foncée
26 . 5 . 2
Two polygons, one inside the other (except 26.5.10 and 26.5.11)Deux polygones, l'un dans l'autre (excepté 26.5.10 et 26.5.11)
26 . 5 . 9
Polygons containing one or more circles or ellipsesPolygones contenant un ou plusieurs cercles ou ellipses
26 . 5 . 16
Polygons containing other figurative elementsPolygones contenant d'autres éléments figuratifs
26 . 5 . 26
Polygons with cutout areasPolygones avec des zones découpées
Trademark usage description
downloadable or recorded computer software to diagnose medical conditions, to prescribe medical treatment and prescriptions, to design clinical trials Read MoreClassification Information
Class [009]
Downloadable or recorded computer software to diagnose medical conditions, to prescribe medical treatment and prescriptions, to design clinical trials and forecast clinical trial results, to search for clinical trial patients, to analyze medical images, to analyze data, and to develop pharmaceutical products and chemical compounds.
Classification kind code
12
Class [042]
Pharmaceutical research and development services; scientific research and development of pharmaceutical preparations; pharmaceutical research services, namely, developing new uses for pharmaceutical compounds through the use of computer models, animal models, and controlled environments; contract research services in support of scientific research and development of pharmaceutical preparations; technical consultancy and services in relation to technical research in the field of pharmaceuticals; consultancy in relation to scientific research in the field of pharmaceuticals; providing medical research and scientific research information in the field of medicine and pharmaceuticals; drug discovery services; scientific and technological services, namely, medical laboratories, scientific research and design for others in the field of pharmaceuticals, conducting and evaluating clinical trials; software as a service (SaaS) featuring software to diagnose medical conditions, to prescribe medical treatment and prescriptions, to design clinical trials and forecast clinical trial results, to search for clinical trial patients, to analyze medical images, to analyze data, and to develop pharmaceutical products and chemical compounds; providing an online searchable database in the fields of pharmaceutical research and development, scientific research and development of pharmaceutical preparations, developing new uses for pharmaceutical compounds, technical research in the field of pharmaceuticals, drug use, drug discovery, and biology understanding; providing an online database in the fields of pharmaceutical research and development, scientific research and development of pharmaceutical preparations, developing new uses for pharmaceutical compounds, technical research in the field of pharmaceuticals, drug use, drug discovery, and biology understanding.
Classification kind code
12
Mark Details
Serial Number
2315467
Mark Type
Trademark
Legal History
| Action Taken | Status |
|---|---|
| Submitted for opposition 48 on 04th Apr 2024 | Agent Changed |
| Submitted for opposition 257 on 14th Mar 2024 | Designation Notification - Madrid Protocol |
| Submitted for opposition 31 on 14th Mar 2024 | Formalized |
| Submitted for opposition 1 on 13th Mar 2024 | Created |
| Submitted for opposition 30 on 13th Dec 2023 | Filed |
| Submitted for opposition 228 on 13th Dec 2023 | International Registration |